Showing results (111-120 of 151) with videos related to
Sort By:
Pageof 16
Gynecologic Oncology|July 17, 2021
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal CancerFloor J Backes, Lai Wei, Min Chen, et al.Journal of Cancer Survivorship : Research and Practice|January 24, 2024
Changes in prospectively collected patient-reported outcomes among women with incident endometrial cancerJennifer A Sinnott, Elaheh Torkashvand, Caitlin E Meade, et al.Gynecologic Oncology|September 22, 2021
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG studyLari Wenzel, Helen Q Huang, David Cella, et al.Gynecologic Oncology|December 5, 2023
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinomaJoyce N Barlin, Barb Mahar, Ashar Ata, et al.Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.Journal of Minimally Invasive Gynecology|February 5, 2022
Surgical Science-Simbionix Robotic Hysterectomy Simulator: Validating a New ToolAdela G Cope, Jose J Lazaro-Weiss, Brooke E Willborg, et al.Gynecologic Oncology|August 21, 2016
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysisKathleen N Moore, James J Java, Katrina N Slaughter, et al.American Journal of Obstetrics and Gynecology|August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancerMichelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.Clinical and Translational Medicine|January 10, 2026
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumoursRachel N Grisham, Elizabeth Hopp, Kathryn Pennington, et al.Obesity (Silver Spring, Md.)|November 4, 2024
Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight lossAshley S Felix, Jennifer A Sinnott, Bette J Caan, et al.Pageof 16